A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

1. Rubio, J.C.
2. Vázquez, S.
3. Vázquez, F.
4. Amenedo, M.
5. Fírvida, J.L.
6. Mel, J.R.
7. Huidobro, G.
8. Álvarez, E.
9. Lázaro, M.
10. Alonso, G.
11. Fernández, I.